Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Debra Ritzwoller and Stacey Honda.
Connection Strength

2.506
  1. Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium. J Gen Intern Med. 2023 Oct 02.
    View in: PubMed
    Score: 0.235
  2. Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium. JCO Clin Cancer Inform. 2023 Sep; 7:e2300063.
    View in: PubMed
    Score: 0.234
  3. Individuals Eligible for Lung Cancer Screening Less Likely to Receive Screening When Enrolled in Health Plans With Deductibles. Med Care. 2023 Oct 01; 61(10):665-673.
    View in: PubMed
    Score: 0.233
  4. Smoking status and the association between patient-level factors and survival among lung cancer patients. J Natl Cancer Inst. 2023 08 08; 115(8):937-948.
    View in: PubMed
    Score: 0.233
  5. Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer. Cancer Treat Res Commun. 2023; 36:100730.
    View in: PubMed
    Score: 0.231
  6. Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening. Am J Prev Med. 2023 Jan 25.
    View in: PubMed
    Score: 0.225
  7. Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening. J Thorac Oncol. 2022 12; 17(12):1355-1364.
    View in: PubMed
    Score: 0.219
  8. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open. 2021 10 01; 4(10):e2128176.
    View in: PubMed
    Score: 0.205
  9. Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: the PROSPR Consortium. Ann Am Thorac Soc. 2021 Sep 20.
    View in: PubMed
    Score: 0.205
  10. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prev Res (Phila). 2020 02; 13(2):129-136.
    View in: PubMed
    Score: 0.181
  11. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study. Ann Intern Med. 2024 Jan; 177(1):18-28.
    View in: PubMed
    Score: 0.060
  12. Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence. Am J Respir Crit Care Med. 2022 Oct 28.
    View in: PubMed
    Score: 0.055
  13. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
    View in: PubMed
    Score: 0.054
  14. Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-up Care: A Multicenter Cohort Study. Ann Am Thorac Soc. 2022 Feb 15.
    View in: PubMed
    Score: 0.053
  15. Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
    View in: PubMed
    Score: 0.048
  16. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323.
    View in: PubMed
    Score: 0.036

© 2024 Kaiser Permanente